Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651929.RAflH4EiWEw56fnrDixRBdqz8oWdGuvCURQS_o-yOoGV8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651929.RAflH4EiWEw56fnrDixRBdqz8oWdGuvCURQS_o-yOoGV8130_assertion type Assertion NP651929.RAflH4EiWEw56fnrDixRBdqz8oWdGuvCURQS_o-yOoGV8130_head.
- NP651929.RAflH4EiWEw56fnrDixRBdqz8oWdGuvCURQS_o-yOoGV8130_assertion description "[The systematic effects of ALA-PDT were evaluated using human invasive carcinoma cells (lung adenocarcinoma CL1-5 cells, melanoma A375 cells and breast carcinoma MDA-MB-231 cells).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651929.RAflH4EiWEw56fnrDixRBdqz8oWdGuvCURQS_o-yOoGV8130_provenance.
- NP651929.RAflH4EiWEw56fnrDixRBdqz8oWdGuvCURQS_o-yOoGV8130_assertion evidence source_evidence_literature NP651929.RAflH4EiWEw56fnrDixRBdqz8oWdGuvCURQS_o-yOoGV8130_provenance.
- NP651929.RAflH4EiWEw56fnrDixRBdqz8oWdGuvCURQS_o-yOoGV8130_assertion SIO_000772 19347942 NP651929.RAflH4EiWEw56fnrDixRBdqz8oWdGuvCURQS_o-yOoGV8130_provenance.
- NP651929.RAflH4EiWEw56fnrDixRBdqz8oWdGuvCURQS_o-yOoGV8130_assertion wasDerivedFrom befree-20140225 NP651929.RAflH4EiWEw56fnrDixRBdqz8oWdGuvCURQS_o-yOoGV8130_provenance.
- NP651929.RAflH4EiWEw56fnrDixRBdqz8oWdGuvCURQS_o-yOoGV8130_assertion wasGeneratedBy ECO_0000203 NP651929.RAflH4EiWEw56fnrDixRBdqz8oWdGuvCURQS_o-yOoGV8130_provenance.